Literature DB >> 6412861

Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.

J R Baker, J P O'Connor, P A Metcalf, M R Lawson, R N Johnson.   

Abstract

Fructosamine, a putative measure of serum glycosylated proteins, was measured in 74 subjects referred for oral glucose tolerance tests. A normal range (mean (2 SD] of 1.6 (0.4) mmol/l (40(10) mg/100 ml) derive from results obtained in 83 healthy non-diabetic volunteers permitted the detection of 15 out of 17 (88%) subjects with proved diabetes and yielded only five (9%) false positive diagnoses. Fructosamine concentrations correlated significantly (p less than 0.001) with fasting plasma glucose concentrations (r = 0.76) and glycosylated haemoglobin concentrations (r = 0.70). A longitudinal study suggested that fructosamine concentration was an index of intermediate term (one to three weeks) blood glucose control. Fructosamine concentration was not related to uraemia and did not depend on albumin or total protein concentrations, provided that serum albumin concentrations remained above 30 g/l. Estimation of fructosamine concentrations is a fully automated procedure and may provide a simple means of screening for diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412861      PMCID: PMC1549287          DOI: 10.1136/bmj.287.6396.863

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

Review 1.  The glucose tolerance test: a pitfall in the diagnosis of diabetes mellitus.

Authors:  M D Siperstein
Journal:  Adv Intern Med       Date:  1975

2.  The Amadori rearrangement.

Authors:  J E HODGE
Journal:  Adv Carbohydr Chem       Date:  1955

3.  Glycosylated haemoglobin in renal failure.

Authors:  H Frag; H K Stummvoll; G Schernthaner; M M Müller
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

4.  Glycosylation of plasma protein and its relation to glycosylated hemoglobin in diabetes.

Authors:  D K Yue; K Morris; S McLennan; J R Turtle
Journal:  Diabetes       Date:  1980-04       Impact factor: 9.461

5.  Glycosylated serum protein and hemoglobin A1 levels to measure control of glycemia.

Authors:  A L Kennedy; T J Merimee
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

6.  A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography.

Authors:  R A Cole; J S Soeldner; P J Dunn; H F Bunn
Journal:  Metabolism       Date:  1978-03       Impact factor: 8.694

7.  Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance.

Authors:  P J Dunn; R A Cole; J S Soeldner; R E Gleason
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

8.  Hyperglycaemia and diabetes mellitus.

Authors:  R J Jarrett; H Keen
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

9.  Hemoglobin A1c levels in a diabetes detection program.

Authors:  J V Santiago; J E Davis; F Fisher
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

10.  Increased glycosylation of serum albumin in diabetes mellitus.

Authors:  R Dolhofer; O H Wieland
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

View more
  32 in total

1.  Maternal serum fructosamine and maternofetal glucose and insulin homeostasis in normal pregnancy.

Authors:  H M Hofmann
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Glucevia Fraxinus excelsior Extract Effectively Controls Blood Glucose Levels in Randomized, Controlled Trial.

Authors:  Thomas Ughetto
Journal:  Integr Med (Encinitas)       Date:  2014-08

3.  Fructosamine or glycated haemoglobin as a measure of diabetic control?

Authors:  J Allgrove; B L Cockrill
Journal:  Arch Dis Child       Date:  1988-04       Impact factor: 3.791

4.  An evaluation of serum fructosamine as a marker of the duration of hypoproteinaemic conditions in dogs.

Authors:  S I Thoresen; W P Bredal
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

5.  Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations.

Authors:  F Gregorio; F Ambrosi; P Marchetti; S Cristallini; R Navalesi; P Brunetti; P Filipponi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

6.  Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.

Authors:  J R Baker; R N Johnson; D J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

7.  A review of glycated albumin as an intermediate glycation index for controlling diabetes.

Authors:  H Vernon Roohk; Asad R Zaidi
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Glycated serum protein determination: comparison between thiobarbituric acid and fructosamine assays.

Authors:  T Poli; A Lapolla; M Plebani; A Franchin; D Fedele
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

9.  Evaluation of the fructosamine test for the measurement of plasma protein glycation.

Authors:  R Flückiger; T Woodtli; W Berger
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

10.  Stable patterns of gene expression regulating carbohydrate metabolism determined by geographic ancestry.

Authors:  Jonathan C Schisler; Peter C Charles; Joel S Parker; Eleanor G Hilliard; Sabeen Mapara; Dane Meredith; Robert E Lineberger; Samuel S Wu; Brian D Alder; George A Stouffer; Cam Patterson
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.